• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Research Data
  • Organizations
  • Researchers
  • More
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment
 

Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment

Options
  • Details
  • Files
BORIS DOI
10.7892/boris.61962
Publisher DOI
10.4049/jimmunol.1400028
PubMed ID
25339672
Description
FcαRI (CD89), the human Fc receptor for IgA, is highly expressed on neutrophil granulocytes. In this study, we show that FcαRI induces different forms of neutrophil death, depending on the inflammatory microenvironment. The susceptibility of inflammatory neutrophils from sepsis or rheumatoid arthritis toward death induced by specific mAb, or soluble IgA at high concentrations, was enhanced. Although unstimulated cells experienced apoptosis following anti-FcαRI mAb stimulation, preactivation with cytokines or TLR agonists in vitro enhanced FcαRI-mediated death by additional recruitment of caspase-independent pathways, but this required PI3K class IA and MAPK signaling. Transmission electron microscopy of FcαRI-stimulated cells revealed cytoplasmic changes with vacuolization and mitochondrial swelling, nuclear condensation, and sustained plasma membrane. Coculture experiments with macrophages revealed anti-inflammatory effects of the partially caspase-independent death of primed cells following FcαRI engagement. Our data suggest that FcαRI has the ability to regulate neutrophil viability and to induce different forms of neutrophils depending on the inflammatory microenvironment and specific characteristics of the ligand-receptor interactions. Furthermore, these findings have potential implications for FcαRI-targeted strategies to treat neutrophil-associated inflammatory diseases.
Date of Publication
2014-12
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Language(s)
en
Contributor(s)
Wehrli, Marc
Institut für Pharmakologie
Schorer, Myriam Fabiola
Institut für Pharmakologie
Hlushchuk, Ruslan
Institut für Anatomie
Daudel, Fritz
Universitätsklinik für Intensivmedizin
Villiger, Peter
Universitätsklinik für Rheumatologie, Klinische Immunologie und Allergologie
Miescher, Sylvia
Zuercher, Adrian W.
Djonov, Valentin Georgievorcid-logo
Institut für Anatomie
Simon, Hans-Uweorcid-logo
Institut für Pharmakologie
von Gunten, Stephan
Institut für Pharmakologie
Additional Credits
Institut für Pharmakologie
Institut für Anatomie
Universitätsklinik für Intensivmedizin
Universitätsklinik für Rheumatologie, Klinische Immunologie und Allergologie
Series
Journal of immunology
Publisher
American Association of Immunologists
ISSN
0022-1767
Access(Rights)
restricted
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: ae9592 [15.12. 16:43]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo